Abstract:The diagnosis of multiple sclerosis (MS) is challenging for the lack of a specific diagnostic test. Recent researches in quantitative proteomics, however, offer new opportunities for biomarker discovery and the study of disease pathogenesis. To find more potential protein biomarkers, we used two technologies, 2-dimensional fluorescence difference in-gel electrophoresis (2D-DIGE), followed by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) and ultra-performance liquid chromato-graph coupled with quadrupole time-of-flight mass spectrometry (UPLC/Q-TOF MS), to quantitatively analyse differential proteomic expression in the cerebrospinal fluid (CSF) between patients with MS (the experiment group) and patients with other neurological diseases (ONDs; the control group). Analysis by the former technology identified more than 43 different protein spots (39 proteins), of which 17 spots (13 proteins) showed more than 1.5-fold difference in abundance as analysed by DeCyder software (GE Healthcare, Piscataway. NJ, USA) between the MS and the ONDs groups. The expression of five protein spots was elevated and the expression of 12 protein spots was decreased in the MS group. Meanwhile, the latter method, UPLC/Q-TOF MS showed 68 different proteins. There were 45 proteins with a difference of more than 1.5 folds between the two groups, in which the expression of 20 proteins was elevated and the expression of 25 proteins was decreased in the MS group. Data provided by the two methods indicated that the proteins overlapped ratio was 27% in the 26 significant proteins that had the same regulation tendency. The differential CSF proteins were analysed further by biological network and it revealed interaction of them. The subsequent ELISA measuring the concentration of cystatin C (P < 0.01), which was one of the proteins discovered simultaneously with the two technologies, confirmed the results of the two quantitative proteomic analysis. The combination of the two quantitative proteomic technologies was helpful in discovering differentially expressed proteins that may have a connection with MS disease physiology and serve as useful biomarkers for diagnosis and treatment of MS diseases.

Establishment of a two-dimensional electrophoresis technologic platform on neuroproteomics

Characterization of proteome of human cerebrospinal fluid.

Proteomics Identification of Proteins in Human Cortex Using Multidimensional Separations and MALDI Tandem Mass Spectrometer

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

Identification of Glycoproteins in Human Cerebrospinal Fluid with a Complementary Proteomic Approach

Global Protein Differential Expression Profiling of Cerebrospinal Fluid Samples Pooled from Chinese Sporadic CJD and non-CJD Patients

Quantitative Proteomic Analysis of the Cerebrospinal Fluid of Patients with Multiple Sclerosis

Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.

Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry

Proteomics Techniques and Their Applications in Cerebral Ischemia Research

The Establishment of a Technique System for Differential Proteomics of Body Fluids

A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry.

Optimization of the Isolation and Enrichment of S-Nitrosylated Proteins from Brain Tissues of Rodents and Humans with Various Prion Diseases for Itraq-Based Proteomics

Establishment and optimization of two-dimensional polyacrylamide gel electrophoresis for proteome analysis of the human testicular tissue

Establishment of two-dimensional differential gel electrophoresis using cerebrospinal fluid from patients with medulloblas-toma and patients with ependymoma

Proteome Analysis of Biomarkers in the Cerebrospinal Fluid of Neuromyelitis Optica Patients.

Study on Proteomic Profile of Normal Ependyma and Ependymoma of Spinal Cord by Using Three-Diamensional Shot-gun and MS/MS Technology

Advances in Proteomics Allow Insights Into Neuronal Proteomes

Proteomics and Neuroscience:From Protein to Network

Two dimensional electrophoresis analysis and mass spectrometry identification of proteins in transected rat spinal cord

Identification of Discrepant Proteins Between Normal Ependyma and Ependymoma of Spinal Cord by Using Proteomics Technology